| Project/Area Number |
25640087
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Tumor therapeutics
|
|---|
| Research Institution | Akita University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2013-04-01 – 2015-03-31
|
| Project Status |
Completed (Fiscal Year 2014)
|
| Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2013: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Keywords | チアカリックスアレーン / 抗がん剤 / 細胞周期 |
|---|
| Outline of Final Research Achievements |
Thiacalixarenes, cyclic oligomers of p-alkylphenol bridged by sulfur atoms, are supramolucules known to have potent coordinating ability to metal ions. We have found so far that thiacalix[6]arene hexasulfate (TC6AHS) affects the distribution of cell cycle in leukemia cell lines. In this study, we aimed to elucidate the effect of newly-synthesized TC6AHS derivatives on the cell cycle progression and the proliferation. Thiacalix[6] arene (TC6A) was found to be induced the arrest at the G1 phase, while TC6AHS arrested at the G2/M phase. Moreover, TC6A exihibited a potent anti-proliferative activity against Jurkat cells, as compared to TC6AHS.
|
